Literature DB >> 31451775

Structural restrictions for influenza neuraminidase activity promote adaptation and diversification.

Hao Wang1, Dan Dou1, Henrik Östbye1, Rebecca Revol1, Robert Daniels2,3.   

Abstract

Influenza neuraminidase (NA) is a sialidase that contributes to viral mobility by removing the extracellular receptors for the haemagglutinin (HA) glycoprotein. However, it remains unclear why influenza NAs evolved to function as Ca2+-dependent tetramers that display variable stability. Here, we show that the Ca2+ ion located at the centre of the NA tetramer is a major stability determinant, as this Ca2+ ion is required for catalysis and its binding affinity varies between NAs. By examining NAs from 2009 pandemic-like H1N1 viruses, we traced the affinity variation to local substitutions that cause residues in the central Ca2+-binding pocket to reposition. A temporal analysis revealed that these local substitutions predictably alter the stability of the 2009 pandemic-like NAs and contribute to the tendency for the stability to vary up and down over time. In addition to the changes in stability, the structural plasticity of NA was also shown to support the formation of heterotetramers, which creates a mechanism for NA to obtain hybrid properties and propagate suboptimal mutants. Together, these results demonstrate how the structural restrictions for activity provide influenza NA with several mechanisms for adaptation and diversification.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31451775     DOI: 10.1038/s41564-019-0537-z

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   17.745


  65 in total

1.  Mucin as substrate of enzyme action by viruses of the mumps influenza group.

Authors:  F M BURNET; J F McCREA; S G ANDERSON
Journal:  Nature       Date:  1947-09-20       Impact factor: 49.962

2.  Mucins and mucoids in relation to influenza virus action; inhibition of virus haemagglutination by glandular mucins.

Authors:  F M BURNET
Journal:  Aust J Exp Biol Med Sci       Date:  1948-09

3.  Mucins and mucoids in relation to influenza virus action; the destruction of Francis inhibitor activity in a purified mucoid by virus action.

Authors:  F M BURNET
Journal:  Aust J Exp Biol Med Sci       Date:  1948-09

4.  Influenza virus pleiomorphy characterized by cryoelectron tomography.

Authors:  Audray Harris; Giovanni Cardone; Dennis C Winkler; J Bernard Heymann; Matthew Brecher; Judith M White; Alasdair C Steven
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-04       Impact factor: 11.205

5.  Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium.

Authors:  Mikhail N Matrosovich; Tatyana Y Matrosovich; Thomas Gray; Noel A Roberts; Hans-Dieter Klenk
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

6.  Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid.

Authors:  W Weis; J H Brown; S Cusack; J C Paulson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1988-06-02       Impact factor: 49.962

7.  A beneficiary role for neuraminidase in influenza virus penetration through the respiratory mucus.

Authors:  Xiaoyun Yang; Lennert Steukers; Katrien Forier; Ranhua Xiong; Kevin Braeckmans; Kristien Van Reeth; Hans Nauwynck
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

Review 8.  Influenza virus-mediated membrane fusion: determinants of hemagglutinin fusogenic activity and experimental approaches for assessing virus fusion.

Authors:  Brian S Hamilton; Gary R Whittaker; Susan Daniel
Journal:  Viruses       Date:  2012-07-24       Impact factor: 5.048

9.  Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase.

Authors:  Miriam Cohen; Xing-Quan Zhang; Hooman P Senaati; Hui-Wen Chen; Nissi M Varki; Robert T Schooley; Pascal Gagneux
Journal:  Virol J       Date:  2013-11-22       Impact factor: 4.099

Review 10.  Influenza A Virus Cell Entry, Replication, Virion Assembly and Movement.

Authors:  Dan Dou; Rebecca Revol; Henrik Östbye; Hao Wang; Robert Daniels
Journal:  Front Immunol       Date:  2018-07-20       Impact factor: 7.561

View more
  11 in total

1.  Design of the Recombinant Influenza Neuraminidase Antigen Is Crucial for Its Biochemical Properties and Protective Efficacy.

Authors:  Jin Gao; Laura Klenow; Lisa Parsons; Tahir Malik; Je-Nie Phue; Zhizeng Gao; Stephen G Withers; John Cipollo; Robert Daniels; Hongquan Wan
Journal:  J Virol       Date:  2021-10-06       Impact factor: 5.103

2.  Antigenic comparison of the neuraminidases from recent influenza A vaccine viruses and 2019-2020 circulating strains.

Authors:  Jin Gao; Xing Li; Laura Klenow; Tahir Malik; Hongquan Wan; Zhiping Ye; Robert Daniels
Journal:  NPJ Vaccines       Date:  2022-07-14       Impact factor: 9.399

3.  N-Linked Glycan Sites on the Influenza A Virus Neuraminidase Head Domain Are Required for Efficient Viral Incorporation and Replication.

Authors:  Henrik Östbye; Jin Gao; Mira Rakic Martinez; Hao Wang; Jan-Willem de Gier; Robert Daniels
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

4.  N-Linked Glycosylation Plays an Important Role in Budding of Neuraminidase Protein and Virulence of Influenza Viruses.

Authors:  Danqi Bao; Ruixue Xue; Min Zhang; Chenyang Lu; Tianxin Ma; Chaochao Ren; Ting Zhang; Jianmei Yang; Qiaoyang Teng; Xuesong Li; Zejun Li; Qinfang Liu
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

5.  Analysis of the Evolution of Pandemic Influenza A(H1N1) Virus Neuraminidase Reveals Entanglement of Different Phenotypic Characteristics.

Authors:  Meiling Dai; Wenjuan Du; Carles Martínez-Romero; Tim Leenders; Tom Wennekes; Guus F Rimmelzwaan; Frank J M van Kuppeveld; Ron A M Fouchier; Adolfo Garcia-Sastre; Erik de Vries; Cornelis A M de Haan
Journal:  mBio       Date:  2021-05-11       Impact factor: 7.867

Review 6.  The Importance of Vaccinating Children and Pregnant Women against Influenza Virus Infection.

Authors:  Ravi S Misra; Jennifer L Nayak
Journal:  Pathogens       Date:  2019-11-26

Review 7.  Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine.

Authors:  Luca T Giurgea; David M Morens; Jeffery K Taubenberger; Matthew J Memoli
Journal:  Vaccines (Basel)       Date:  2020-07-23

Review 8.  Influenza Neuraminidase Characteristics and Potential as a Vaccine Target.

Authors:  Sarah Creytens; Mirte N Pascha; Marlies Ballegeer; Xavier Saelens; Cornelis A M de Haan
Journal:  Front Immunol       Date:  2021-11-16       Impact factor: 7.561

9.  Structure-based design of stabilized recombinant influenza neuraminidase tetramers.

Authors:  Daniel Ellis; Julia Lederhofer; Oliver J Acton; Yaroslav Tsybovsky; Sally Kephart; Christina Yap; Rebecca A Gillespie; Adrian Creanga; Audrey Olshefsky; Tyler Stephens; Deleah Pettie; Michael Murphy; Claire Sydeman; Maggie Ahlrichs; Sidney Chan; Andrew J Borst; Young-Jun Park; Kelly K Lee; Barney S Graham; David Veesler; Neil P King; Masaru Kanekiyo
Journal:  Nat Commun       Date:  2022-04-05       Impact factor: 17.694

10.  Plasticity of the 340-Loop in Influenza Neuraminidase Offers New Insight for Antiviral Drug Development.

Authors:  Nanyu Han; Justin Tze Yang Ng; Yanpeng Li; Yuguang Mu; Zunxi Huang
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.